1. Home
  2. FTI vs RVMD Comparison

FTI vs RVMD Comparison

Compare FTI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechnipFMC plc

FTI

TechnipFMC plc

HOLD

Current Price

$78.37

Market Cap

29.1B

Sector

Industrials

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$202.97

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTI
RVMD
Founded
1884
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1B
30.1B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
FTI
RVMD
Price
$78.37
$202.97
Analyst Decision
Buy
Strong Buy
Analyst Count
13
19
Target Price
$65.50
$140.84
AVG Volume (30 Days)
2.8M
1.7M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
0.26%
N/A
EPS Growth
20.42
N/A
EPS
1.53
N/A
Revenue
$9,932,600,000.00
N/A
Revenue This Year
$8.49
N/A
Revenue Next Year
$5.53
$533.02
P/E Ratio
$50.12
N/A
Revenue Growth
9.35
N/A
52 Week Low
$34.27
$35.42
52 Week High
$77.92
$208.76

Technical Indicators

Market Signals
Indicator
FTI
RVMD
Relative Strength Index (RSI) 66.64 61.95
Support Level $66.61 $177.04
Resistance Level N/A N/A
Average True Range (ATR) 2.73 7.01
MACD 0.62 0.56
Stochastic Oscillator 94.31 78.15

Price Performance

Historical Comparison
FTI
RVMD

About FTI TechnipFMC plc

TechnipFMC PLC is the key provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies. Geographically it operates in Latin America generating the maximum revenue, then Europe and Central Asia, Africa, North America, Asia Pacific and Middle East.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: